Biotech · Private company
Graviton Bioscience Corporation
Track this companyFree. Adds Graviton Bioscience Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- GV101Phase 2 · Friedreich's AtaxiaClinicalTrials.gov · fetched Nov 12, 2026
- GV101Phase 2 · Weight ManagementClinicalTrials.gov · fetched Nov 12, 2026
- GV101Phase 1 · Phase 1ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- GV101 for Friedreich's Ataxia (FA) TreatmentPHASE2 · NOT_YET_RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07870590 · fetched Nov 12, 2026
- GV101 in Healthy Obese ParticipantsPHASE2 · COMPLETED · started Jun 30, 2025ClinicalTrials.gov NCT06979505 · fetched Nov 12, 2026
- Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Dose of GV101 in Healthy SubjectsPHASE1 · COMPLETED · started Sep 10, 2021ClinicalTrials.gov NCT05068947 · fetched Nov 12, 2026